IV Administration of ChromaDex's Niagen® as Compared to NAD+
Active Not Recruiting
This is a 2-part study evaluating the effects of IV administration of NR on healthy adult populations. Study 1 involved all four arms with 37 people. The second study only included the active NR and NAD+ arms to further evaluate tolerability and comfort of the IV.
Gender:
ALL
Ages:
40 years and above
Trial Updated:
04/23/2024
Locations: Nutraceuticals Research Institute, Franklin, Tennessee
Conditions: Healthy Aging